CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2018; 28(04): 406-411
DOI: 10.4103/ijri.IJRI_228_18
Neuroradiology & Head and Neck Imaging

Isolated spontaneous cerebrospinal fluid rhinorrhoea as a rare presentation of idiopathic intracranial hypertension: Case reports with comprehensive review of literature

Priti Soin
Department of Pathology and Laboratory Medicine, Weil Cornell College of Medicine, New York
,
Umer M Afzaal
Department of Radiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
,
Pranav Sharma
Department of Radiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
,
Puneet S Kochar
Department of Radiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
› Author Affiliations

Subject Editor: Financial support and sponsorship Nil.

Abstract

Isolated cerebrospinal fluid (CSF) rhinorrhoea as a sole presenting symptom of idiopathic intracranial hypertension (IIH) is extremely rare. IIH typically presents with headache, pulsatile tinnitus, dizziness, nausea, vomiting, and visual disturbance. We report two cases which presented with acute onset spontaneous CSF rhinorrhoea without any other symptom. In addition, we discuss in detail imaging features of IIH with review of its literature.



Publication History

Article published online:
26 July 2021

© 2018. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78: 89-94
  • 2 Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumorcerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-7
  • 3 Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM. Idiopathic intracranialhypertension (pseudotumorcerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neuro 150: 78-80
  • 4 Jensen RH, Radojicic A, Yri H. The diagnosis and management ofidiopathic intracranial hypertensionand theassociatedheadache. Ther Adv Neurol Disord 2016; 9: 317-26
  • 5 Shaw GY, Million SK. Benign intracranial hypertension: Adiagnostic dilemma. Case Rep Otolaryngol 2012; 2012: 814696
  • 6 Clark D, Bullock P, Hui T, Firth J. Benign intracranial hypertension: Acause of CSF rhinorrhoea. JNeurolNeurosurgPsychiatry 1994; 57: 847-9
  • 7 Saifudheen K, Gafoor A, Arun G, Abdurahiman P, Jose J. Idiopathicintracranial hypertension presenting as CSF rhinorrhea. Ann Indian AcadNeurol 2010; 13: 72-3
  • 8 Rosenfeld E, Dotan G, Kimchi T, Kesler A. Spontaneous cerebrospinal fluid otorrhea and rhinorrhea in idiopathic intracranial hypertension patients. J Neuroophthalmol 2013; 33: 113-6
  • 9 Pérez MA, Bialer OY, Bruce BB. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 2013; 33: 327-34
  • 10 Baykan B, Ekizoglu E, Altıokka Uzun G. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumorcerebri. Agri. 2015; 27: 63-72
  • 11 Phillips PH, Repka MX, Lambert SR. Pseudotumorcerebri in children. J AAPOS 1998; 2: 33-8
  • 12 Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2006; 26: 384-99
  • 13 Sinclair AJ, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ. et al. Exploring the pathogenesis of IIH: An inflammatory perspective. J Neuroimmunol 2008; 201-2: 212-20
  • 14 Sahs AJ, Joynt RJ. Brain swelling of unknown cause. Neurology 1956; 6: 791-803
  • 15 Moser FG, Hilal SK, Abrams G, Bello JA, Schipper H, Silver AJ. MR imaging of pseudotumorcerebri. AJR Am J Roentgenol 1988; 150: 903-9
  • 16 Dandy WE. Intracranial pressure without brain tumor: Diagnosis and treatment. Ann Surg 1937; 106: 492-513
  • 17 Malm J, Kristensen B, Markgren P, Ekstedt J. CSF hydrodynamics in idiopathic intracranial hypertension: Along-term study. Neurology 1992; 42: 851-8
  • 18 Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA. et al. Idiopathic intracranial hypertension in men. Neurology 2009; 72: 304-9
  • 19 Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ. et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumorcerebri). Am J Ophthalmol 2007; 143: 635-41
  • 20 Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI. et al. Weight gain and recurrence in idiopathic intracranial hypertension: Acase-control study. Neurology 2011; 76: 1564-7
  • 21 Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: Relation between obesity and visual outcomes. J Neuroophthalmol 2013; 33: 4-8
  • 22 Johnson LN, Krohel GB, Madsen RW, March Jr. GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumorcerebri). Ophthalmology 1998; 105: 2313-7
  • 23 Sugerman HJ, DeMaria EJ, Felton 3rd WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumorcerebri. Neurology 1997; 49: 507-11
  • 24 Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005; 64: 1893-6
  • 25 Warner JE, Larson AJ, Bhosale P, Digre KB, Henley C, Alder SC. et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007; 27: 258-62
  • 26 Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: Characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127: 178-82
  • 27 Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med 2005; 145: 72-82
  • 28 Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: Associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003; 142: 35-45
  • 29 Skau M, Goetze JP, Rehfeld JF, Jensen R. Natriuretic propeptides in idiopathic intracranial hypertension. RegulPept 2010; 164: 71-7
  • 30 Johansson PA, Dziegielewska KM, Ek CJ, Habgood MD, Møllgård K, Potter A. et al. Aquaporin-1 in the choroid plexuses of developing mammalian brain. Cell Tissue Res 2005; 322: 353-64
  • 31 Umenishi F, Schrier RW. Induction of human aquaporin-1 gene by retinoic acid in human erythroleukemia HEL cells. BiochemBiophys Res Commun 2002; 293: 913-7
  • 32 Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ. et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013; 80: 289-95
  • 33 McGeeney BE, Friedman DI. Pseudotumorcerebri pathophysiology. Headache 2014; 54: 445-58
  • 34 Stevens SA, Previte M, Lakin WD, Thakore NJ, Penar PL, Hamschin B. Idiopathic intracranial hypertension and transverse sinus stenosis: Amodelling study. Math Med Biol 2007; 24: 85-109
  • 35 Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: Areview of the literature. J NeurointervSurg 2013; 5: 483-6
  • 36 Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg 2012; 116: 538-48
  • 37 Rohr A, Dörner L, Stingele R, Buhl R, Alfke K, Jansen O. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007; 28: 656-9
  • 38 Bono F, Messina D, Giliberto C, Cristiano D, Broussard G, Fera F. et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 2006; 67: 419-23
  • 39 Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114: 155-80
  • 40 Headache Classification Subcommittee of the International Headache Society. The International classification of headache disorders. 2nd Edition. Cephalalgia. 2004. 24. Suppl 1 9-160
  • 41 Bono F, Quattrone A. Idiopathic intracranial hypertension without papilloedema in headache sufferers. Cephalalgia 2009; 29: 594
  • 42 Smith JL. Whence pseudotumorcerebri?. J ClinNeuroophthalmol 1985; 5: 55-6
  • 43 Wall M. Idiopathic intracranial hypertension. NeurolClin 2010; 28: 593-617
  • 44 Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-5
  • 45 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumorcerebri syndrome in adults and children. Neurology 2013; 81: 1159-65
  • 46 Suzuki H, Takanashi J, Kobayashi K, Nagasawa K, Tashima K, Kohno Y. MR imaging of idiopathic intracranial hypertension. Am J Neuroradiol 2001; 22: 196-9
  • 47 Shetty PG, Shroff MM, Sahani DV, Kirtane MV. Evaluation of high-resolution CT and MR cisternography in the diagnosis of cerebrospinal fluid fistula. AJNR Am J Neuroradiol 1998; 19: 633-9